Walgreens Boots Alliance Inc
SWB:W8A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (0.3), the stock would be worth €10.34 (0% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | €10.39 |
0%
|
| 3-Year Average | 0.3 | €10.34 |
0%
|
| 5-Year Average | 0.4 | €11.76 |
+13%
|
| Industry Average | 1.7 | €54.73 |
+427%
|
| Country Average | 1.5 | €48.96 |
+371%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Walgreens Boots Alliance Inc
SWB:W8A
|
10.4B EUR | 0.3 | -1.6 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62B ZAR | 7.3 | 19.2 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 3.1 | 25.3 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.3B BRL | 2.6 | 29.7 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
937.7B JPY | 0.8 | 22 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
922.6B JPY | 1.6 | 16.5 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 3.7 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.1B CNY | 2.2 | 16.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 1.9 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
563.9B JPY | 1.6 | 12.5 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
21.3B CNY | 1.7 | 16.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.5 |
| 70th Percentile | 2.9 |
| Max | 566 432.7 |
Other Multiples
Walgreens Boots Alliance Inc
Glance View
In the world of retail pharmacy, Walgreens Boots Alliance Inc. stands as a formidable player, weaving a complex tapestry that spans across more than two dozen countries. Born from the merger of Walgreens, an iconic American pharmacy chain, and Alliance Boots, a European health and beauty group, this company marries a vast network of retail pharmacies with an integrated healthcare strategy. At the heart of its operations is the retail pharmacy segment, where customers are served both prescription medications and over-the-counter health products alongside a curated selection of wellness and beauty offerings. By integrating in-store pharmacists who administer vaccines and provide health consultations, Walgreens Boots Alliance enhances its core pharmacy business, ensuring that health professionals and strategic store placement work hand-in-hand to deliver comprehensive health solutions. Beyond the familiar aisles of their retail pharmacies, Walgreens Boots Alliance generates additional revenue through its pharmaceutical wholesale division, which supplies medicines and healthcare products to pharmacies, doctors, and hospitals. This segment boosts its financial ecosystem by leveraging strategic partnerships with major pharmaceutical companies, ensuring steady supply chains and competitive pricing. The company's ability to adapt to the digital age further amplifies its operations; through e-commerce platforms and digital health services, it stays attuned to the evolving needs of its clientele. Operating at the intersection of healthcare and retail, Walgreens Boots Alliance is not just a dispenser of medicines but a strategic navigator in the healthcare sector, maneuvering through complex market dynamics to maintain its influential position.